Syneos Health (SYENS) | Stock Overview & Key Data
Syneos Health, Inc. | Large-cap | Basic Materials
Syneos Health, Inc. | Large-cap | Basic Materials
Syneos Health Performance Comparison
Stock Range
Today's Range
Low: €76.58
High: €78.24
on August 8, 2025
52 Week Range
Low: €53.70
High: €84.85
on April 7, 2025
on February 14, 2025
All-Time High: €109.90 on December 11, 2023
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Market Cap
€7.4B
EPS
-0.81
P/E Ratio (TTM)
377.86
Forward P/E
9.75
P/B Ratio
1.20
PEG Ratio
9.75
Div. Yield
N/A
ROE
-1.20%
Beta
N/A
Debt to Equity
45.57
Financial Highlights
Profitability
Gross Margin
30.87%
Operating Margin
10.86%
Profit Margin
-1.30%
Returns and Earnings
Return on Assets (TTM)
3.16%
Return on Equity (TTM)
-1.20%
EBITDA
€1.4B
Net Income (TTM)
€-87.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€64.44
Quarterly Revenue Growth (YoY)
-7.60%
Quarterly Earnings Growth (YoY)
72.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Syneos Health SYENS | 7.41B Large-cap | 10.13% | 13.46% | 22.32% | -2.41% | 11.12% | 12.17% | -17.42% | -17.42% |
| Solvay SA SOLB | 2.93B Large-cap | 3.49% | -3.66% | -7.05% | -5.98% | -8.07% | -8.66% | -67.35% | -61.28% |
| Solvac S.A SOLV | 1.99B Large-cap | 3.82% | 5.00% | 1.54% | -9.85% | -6.85% | -10.29% | -9.41% | 1.54% |
| Azelis Group NV AZE | 3.24B Large-cap | 2.57% | 0.15% | -2.02% | -31.43% | -29.72% | -21.45% | -42.68% | -51.61% |
| Titan Cement TITC | 2.70B Large-cap | 5.58% | -1.56% | -3.57% | -14.85% | -4.66% | 25.75% | 212.81% | 237.95% |
| Tessenderlo Group NV TESB | 1.62B Large-cap | 2.09% | 2.87% | 1.51% | 29.40% | 39.55% | 14.99% | -10.80% | 0.94% |
Ownership & Short Interest
Insider Ownership
31.39%
Institutional Ownership
27.65%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
125K
Average 90-Day Volume
108K
Syneos Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Syneos Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SYENS's 52-week high and low?
- In the last 52 weeks, Syneos Health reached a high of €84.85 (on February 14, 2025) and a low of €53.70 (on April 7, 2025).
- What is the market cap and P/E ratio for SYENS?
- Curious about Syneos Health's size and valuation? Its market capitalization stands at 7.41B. When it comes to valuation, the P/E ratio (trailing twelve months) is 377.86, and the forward P/E (looking ahead) is 9.75.
- Does SYENS pay dividends? If so, what's the yield?
- As for dividends, Syneos Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Syneos Health's main competitors or similar companies to consider before investing?
When looking at Syneos Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Solvay SA
SOLB2.93B Basic Materials Chemicals -8.66% -67.35% Solvac S.A
SOLV1.99B Basic Materials Chemicals -10.29% -9.41% Azelis Group NV
AZE3.24B Basic Materials Specialty Chemicals -21.45% -42.68% Titan Cement
TITC2.70B Basic Materials Building Materials 25.75% 212.81% Tessenderlo Group NV
TESB1.62B Basic Materials Agricultural Inputs 14.99% -10.80% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Syneos Health, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Syneos Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.20%, the Debt to Equity ratio from the most recent quarter is 45.57, and its Gross Profit Margin stands at 30.87%.
- What is the recent revenue and earnings growth for SYENS?
- Looking at Syneos Health's growth, its revenue over the trailing twelve months (TTM) was €7B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.60%, and quarterly earnings saw a YoY growth of 72.40%.
- How much of SYENS stock is held by insiders and institutions?
- Wondering who owns Syneos Health stock? Company insiders (like executives and directors) hold about 31.39% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 27.65%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.